In 2010, Bentall and John Read co-authored a literature review on "The effectiveness of electroconvulsive therapy" (ECT). It examined placebo-controlled studies and concluded ECT had minimal benefits for people with depression and schizophrenia. The authors said "given the strong evidence of persistent and, for some, permanent brain dysfunction, primarily evidenced in the form of retrograde and anterograde amnesia, and the evidence of a slight but significant increased risk of death, the cost-benefit analysis for ECT is so poor that its use cannot be scientifically justified". Psychiatrists, however, sharply criticized this paper in passing by calling it an ""evidence-poor paper with an anti-ECT agenda"".